The Almac Group Celebrates Grand Opening of New North American Headquarters
The Almac Group on Wednesday, May 18 celebrated the official grand opening of its new North American Headquarters in Souderton, PA.
The $120 million, 240,000-square-foot new North American headquarters houses more than 800 employees and has already brought approximately 300 new hires to the greater Philadelphia region. With global headquarters in Craigavon, Northern Ireland, Almac employs more than 3,000 worldwide, with over 1,100 employees based in the US.
Officially opening the building was former US Senator George J. Mitchell, who was Chairman of the historic 1998 Northern Ireland Peace Agreement. Until last week, Mitchell served as President Obama’s Special Envoy to the Middle East. Commenting on the new facility, Mitchell said, “Almac’s Founder Sir Allen McClay had a real vision for this company, and the building we are dedicating today will be a fitting monument to his life and work. This facility will be important not only to the economy of Pennsylvania, but to the health of people all over the world."
In addition to Senator Mitchell, several other dignitaries participated in the grand opening. These include Pennsylvania Department of Community and Economic Development Secretary C. Alan Walker, who attended on behalf of Pennsylvania Governor Tom Corbett, and Almac CEO Alan Armstron.
Lady Heather McClay, wife of the late Sir Allen McClay , dedicated three unique pieces of stained glass commissioned especially for the headquarters. The glass works are interwoven with scientific references, symbols associated with Northern Ireland, as well as images from the official crest of Pennsylvania.
Almac’s new North American headquarters, comprised of a three-story office and administration building, as well as a building for the production, analysis and distribution of clinical trial supplies, was designed by Francis Cauffman Architects of Philadelphia and built by Skanska USA. It strives to maintain sustainability throughout, with low greenhouse gas emissions and a full water reclamation program in place.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
